Company Overview

Update
Headquarters:
Berlin-baumschulenweg
Funding:
$16M
Categories:
Biotechnology

caprotec bioanalytics developed a proprietary capture protein technology to reduce the complexity of protein mixtures and samples.

Description

Update

caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner.

caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.

Current Team (1)

Update

Funding Rounds (3) - $16M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Berlin-baumschulenweg,

    DEU

Images (1)

Update
  • 88d36a8a2d2e5d83d2aba605f9d5ba36